NCT00618774View on ClinicalTrials.gov

An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

PHASE3CompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

October 31, 2009

Conditions
Hypertension
Interventions
DRUG

telmisartan40/amlodipine5

DRUG

telmisartan80/amlodipine5

Trial Locations (7)

Unknown

1235.16.004 Boehringer Ingelheim Investigational Site, Chofu, Tokyo

1235.16.006 Boehringer Ingelheim Investigational Site, Nishi-ku, Hiroshima, Hiroshima

1235.16.005 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1235.16.007 Boehringer Ingelheim Investigational Site, Osaka, Osaka

1235.16.003 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo

1235.16.001 Boehringer Ingelheim Investigational Site, Shinjyuku-ku,Tokyo

1235.16.002 Boehringer Ingelheim Investigational Site, Suita, Osaka

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00618774 - An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination | Biotech Hunter | Biotech Hunter